IC
BMRN icon

IEQ Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

IEQ Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Sell
197,988
-203,622
-51% -$11.2M 0.05% 322
2026
Q1 		$22.7M Buy
401,610
+43,554
+12% +$2.54M 0.11% 187
2025
Q4 		$21.3M Sell
358,056
-61,265
-15% -$3.34M 0.06% 198
2025
Q3 		$22.7M Buy
419,321
+163,702
+64% +$9.36M 0.07% 150
2025
Q2 		$14.1M Buy
255,619
+91,043
+55% +$5.36M 0.09% 177
2025
Q1 		$11.6M Buy
164,576
+104,289
+173% +$7.02M 0.09% 172
2024
Q4 		$3.96M Buy
60,287
+53,151
+745% +$3.56M 0.04% 325
2024
Q3 		$502K Buy
+7,136
New +$596K 0.01% 749

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

IEQ Capital's BMRN Position: Q2 2026 in Review

IEQ Capital reduced its BioMarin Pharmaceuticals (BMRN) stake by 51% in Q2 2026, selling an estimated $11.2M and leaving 197,988 shares worth $11.3M. The position accounts for 0.05% of the portfolio, ranked #322.

IEQ Capital first reported a position in BMRN in Q3 2024 and has held it in 8 quarters since. The position peaked at $22.7M in Q3 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • IEQ Capital held 197,988 shares of BioMarin Pharmaceuticals worth $11.3M as of Q2 2026.
  • IEQ Capital sold 203,622 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $11.2M.
  • BioMarin Pharmaceuticals made up 0.05% of IEQ Capital's portfolio in Q2 2026, its #322 holding.
  • IEQ Capital first reported a position in BioMarin Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • IEQ Capital's BioMarin Pharmaceuticals position peaked at $22.7M in Q3 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.